NewsRx

Search our medical news database

Healthcare Coverage

Avalere study finds access to key drugs for many in California has been reduced under Medicare

Published in Law and Health Weekly, April 22nd, 2006

A new analysis shows that many of California's one million dual-eligible beneficiaries receive inferior drug access to key drugs under Medicare Part D compared to their previous state-sponsored Medicaid coverage.

The study, prepared by Avalere Health, was released by the California HealthCare Foundation and will be presented to the California State Assembly.

Using its proprietary DataFrame tool, Avalere Health analyzed CMS' publicly available data from October 2005 to assess if drug coverage for California's dual-eligible beneficiaries is better or worse after the transition to Part D drug plans. Their evaluation of the 10 prescription drug plans...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook